Biome Australia rises on strong FY23 sales revenue
** Shares of microbiome health company Biome Australia
BIO.AX rise as much as 16.7% to A$0.084 - their highest since
May 8
** Co records unaudited FY sales revenue of A$7.23 mln
($4.82 mln), a 75% growth compared to FY22
** Records unaudited sales revenue of A$2 mln for March-June
qtr
** BIO set for best day since June 15, if gains hold
** As of last close, stock up 2.1% YTD
($1 = 1.4988 Australian dollars)
(Reporting by Himanshi Akhand in Bengaluru)
((Himanshi.Akhand@thomsonreuters.com;))
Recent news on Biome Australia
See all newsBrief: Biome Australia To Launch In China
Brief: Biome Australia Posts FY26 Sales Revenue Rises 30% To A$23.9 Million
Biome Australia hits two-month high on upbeat full-year sales revenue
Brief: Biome Australia Logs FY Revenue of AUD 23.9 Million
Biome Australia soars on signing Australian manufacturing deal